NNovo Nordisk Read More Novo Nordisk’s Pipeline Ambitions Clash With Near-Term Revenue Fears as Analysts Flag 2027 Slowdow2026-05-20 Novo Nordisk stock up 26% but analyst warns of 3% revenue drop in 2027. Pipeline with Amycretin and…